In focus · trending topic

Cannabinoid-based Therapy

12 stories · following the connections

Puerto Rican Alzheimer’s Patients to Be First in U.S. to Obtain Cannabis-Based Relief

By Nasdaq OMXMar 26, 2018, 1:44 PM UTC

IGC Announces Adjournment of Annual Meeting Voting for Proposals Three and Four to Dec 15, 2017

By Nasdaq OMXNov 22, 2017, 10:00 PM UTC

IGC to Distribute its Formulations in Germany in Early 2018

By Nasdaq OMXOct 25, 2017, 12:00 PM UTC

IGC-AD1 Targeting Alzheimer’s Disease to be commercialized in early 2018 Through Medical Dispensaries

By Nasdaq OMXOct 18, 2017, 12:01 PM UTC

IGC Readies Line of Medical Dispensary Products Targeting Alzheimer’s Disease Based on Novel Data

By Nasdaq OMXSep 18, 2017, 12:01 PM UTC

IGC Announces Financial Results for Quarter Ended June 30, 2017

By Nasdaq OMXAug 21, 2017, 11:00 AM UTC

IGC Acquires Exclusive Rights to THC-based treatment for Alzheimer’s Disease

By Nasdaq OMXJun 12, 2017, 11:36 AM UTC

IGC Files International Patents for IGC-501 Compound Indicated for Neuropathic Pain

By Nasdaq OMXApr 10, 2017, 10:00 AM UTC